Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
iPSCs (induced pluripotent stem cells) are the newest tool used to model PD (Parkinson's disease). Fibroblasts from patients carrying pathogenic mutations that lead to PD have been reprogrammed into iPSCs, which can subsequently be differentiated into important cell types. Given the characteris...
Main Authors: | Beevers, J, Caffrey, T, Wade-Martins, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01) -
An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
by: Li-Jie Hsu, et al.
Published: (2021-09-01) -
A novel method for generating induced pluripotent stem cell (iPSC)-derived alveolar organoids: a comparison of their ability depending on iPSC origin
by: Min Jae Lim, et al.
Published: (2023-07-01) -
Generation of TSC1 knockout induced pluripotent stem cell (iPSC) line
by: Wei Shan, et al.
Published: (2022-10-01) -
Targeting TFEB and TFE3 in iPSC-derived dopaminergic neurons to correct autophagic/lysosomal deficits in Parkinson's disease
by: McGuinness, W
Published: (2023)